MedTrace Logo

Longitudinal Data Registry of Plasma Cell Dyscrasia

NCT06760052 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-01-06

No results posted yet for this study

Summary

This study aims to identify clinical characteristics, response and clinical outcome of plasma cell dyscrasia (PCD) diagnosed in Zhongshan Hospital, Fudan University from May 2023. In its current version, the registry incorporates historical data (collected from 2007) and is prospectively collecting follow-up data and recording patient outcomes.

Conditions

  • Multiple Myeloma and Other Plasma Cell Neoplasms

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06760052 on ClinicalTrials.gov